Although eIF-5A, DHS and DOHH are highly conserved and likewise expressed in healthy tissues, their overexpression in aggressive astrocytomas and the enhanced responsiveness of GMB cells compared to normal astrocytes render these protein potential therapeutic targets in this intracranial neoplasm. The gene discussed is EIF5A; the disease is astrocytoma (excluding glioblastoma).